MD Medical Group opens new clinic in Krasnodar
|Download file (479 K)|
29 November 2019, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has opened its first out-patient clinic in Krasnodar. Investment in the project amounted to around 50 million roubles.
Mother&Child Krasnodar has a total area of 360 sq. m. and is the second medical facility of the Group located in the Southern Federal district of Russia. The clinic offers a wide range of services for women including IVF, ultrasound, gynaecological treatments and antenatal care. Patients will be offered medical consultations with highly qualified obstetricians/gynaecoogists, endocrinologists, urologists and other specialists.
The clinic has annual capacities of up to 1 000 minor gynaecological operations; up to 500 IVF cycles, including under the Mandatory Health Insurance (MHI) programme; and more than 26,000 out-patient treatments per year.
The Krasnodar clinic has been created in line with MD Medical Group’s customary high standards of medical care and is fitted with world-class equipment produced by GE healthcare, Olympus, Origio, KARL STORZ, Oxford Medical, Cook и Nikon.
Mark Kurtser, CEO of MD Medical Group, said:
“Mother and Child has started operating in Krasnodar - a dynamic city in the South of Russia which today is among the top five cities in Russia with the most comfortable living conditions. I am confident that our company - well known for its high standards in providing medical care - will contribute greatly to the improvement of the quality of life of the inhabitants of a wide geographical region, offering them new possibilities in receiving modern and sophisticated medical services, first of all in the the area of woman's health and IVF”.
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 41 20
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 40 modern healthcare facilities, including 6 hospitals and 34 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, and Vladivostok.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements. No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2019 2018 2017 2016 2015 2014 2013 2012